EKF Diagnostics Holdings

EKFHealthcare
26.10GBX
4.40%
Market Cap
117.21M
Volume
679k
112% of avg
P/E Ratio
0.18
EPS (TTM)
1.45
Beta
0.28
Day Range
25.38p - 28.47p
52 Week Range
18.40p26.10p33.00p
26.10p

Upcoming Events

20 May 2025
Annual General Meeting
31 December 2025
FY 2025 financial year end
EKF
GOOD

EKF Diagnostics Delivers Solid Q1 Trading Update

The diagnostics company reports solid Q1 trading, with adjusted EBITDA performance holding up well despite headwinds. The business is on track to deliver growth for the full year in-line with market expectations.

EKF
NEUTRAL

EKF Diagnostics Completes Share Buyback Programme

The healthcare diagnostics company has completed its share buyback programme, repurchasing over 4.6 million shares.

EKF
NEUTRAL

EKF Diagnostics Announces Share Buyback

The healthcare diagnostics company has announced a share buyback program.

EKF
NEUTRAL

EKF Diagnostics Announces Share Buyback

The healthcare diagnostics company has purchased 200,000 of its own shares at an average price of 21 pence per share.

EKF
NEUTRAL

EKF Diagnostics Publishes Annual Report and Notice of AGM

The healthcare diagnostics company has published its annual report and notice of upcoming AGM.

EKF
NEUTRAL

EKF Diagnostics Announces Share Buyback

The healthcare diagnostics company has purchased over 570,000 of its own shares as part of an ongoing buyback program.

EKF
NEUTRAL

EKF Diagnostics Directors Increase Shareholdings

The healthcare diagnostics company's directors have purchased additional shares in the business.

EKF
NEUTRAL

EKF Diagnostics Appoints New CEO

The healthcare diagnostics company has appointed a new Chief Executive Officer to lead the business.

EKF
NEUTRAL

EKF Diagnostics Announces Full Year Results and Investor Presentations

The global diagnostics company will announce its full year results and hold investor presentations on March 25, 2025.